Galectin Therapeutics
GALT
#9132
Rank
A$0.13 B
Marketcap
$2.18
Share price
3.13%
Change (1 day)
-52.06%
Change (1 year)

EPS for Galectin Therapeutics (GALT)

EPS in 2023 (TTM): -$0.99

According to Galectin Therapeutics's latest financial reports the company's current EPS (TTM) is -$1.09. In 2022 the company made an earnings per share (EPS) of -$1.08 a decrease over its 2021 EPS that were of -$0.86.

EPS history for Galectin Therapeutics from 2002 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$0.99-8.01%
2022-$1.0825%
2021-$0.8630%
2020-$0.66-6.98%
2019-$0.7113.16%
2018-$0.63-22.45%
2017-$0.81-35.53%
2016-$1.26-13.64%
2015-$1.4611.39%
2014-$1.31-39.69%
2013-$2.1781.94%
2012-$1.19-32.08%
2011-$1.757.07%
2010-$1.64-17.5%
2009-$1.98150%
2008-$0.79-68%
2007-$2.48127.27%
2006-$1.09-52.17%
2005-$2.28-20.69%
2004-$2.8852.63%
2003-$1.89-13.64%
2002-$2.18

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$21.20 1,842.42%๐Ÿ‡บ๐Ÿ‡ธ USA
-$0.31-71.21%๐Ÿ‡บ๐Ÿ‡ธ USA